Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
H. Pylori Infection
Interventions
DRUG

TAK-438

DRUG

Lansoprazole

DRUG

Amoxicillin

DRUG

Clarithromycin

Trial Locations (35)

Unknown

Abiko-shi

Kashiwa-shi

Fukui-shi

Fukuoka

Ishikari-shi

Sapporo

Kobe

Nishinomiya-shi

Marugame-shi

Takamatsu

Kagoshima

Ebina-shi

Yokohama

Yatsushiro-shi

Kyoto

Ōita

Hirakata-shi

Osaka

Sakai-shi

Suita-shi

Takatsuki-shi

Toyonaka-shi

Saga

Kumagaya-shi

Tokorozawa-shi

Shizuoka

Adachi-ku

Chiyoda-ku

Hachioji-shi

Kokubunji-shi

Nishi-Tokyo-shi

Oota-ku

Ōta-ku

Setagaya-ku

Shibuya-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY